See a Demo

Category: Blog

TrialAssure cubes divider
Outsourcing-Pharma released a State of the Industry report that sheds light on the global pharmaceutical industry. One of the key findings in the report showed that more than half of survey respondents believe that industry initiatives will lead to greater transparency. The report points to a new pilot program launched earlier this year by the FDA to increase transparency. Clinical Trial Transparency Software client feedback

This week in transparency news: November 3-9, 2018

by Staff Writer | November 2018

Posted in Blog
Read More

This week in transparency news: October 27 – November 2, 2018

by Staff Writer | November 2018

Posted in Blog
Read More

This week in transparency news: October 13-26, 2018

by Staff Writer | October 2018

Posted in Blog
Read More
The U.S. Senate had voted in favor of an opioid bill that expands Open Payments to include payments made to Nurse Practitioners, Physician Assistants, Nurse Midwifes, Nurse Anesthetists, and Clinical Nurse Specialists, in addition to current physician reporting requirements. This will go into effect beginning January 1, 2022. Inconsistent Clinical Trial Disclosure and Lack of Compliance Across Big Pharma

This week in transparency news: September 29 – October 12, 2018

by Staff Writer | October 2018

Posted in Blog
Read More
The FDA issued a draft guidance in September 2018 to detail the regulatory body’s thinking on monetary penalties of up to $10,000 per day for failing to register a clinical trial, patterns of previous noncompliance, and/or submitting misleading or false information to ClinicalTrials.gov. While the FDA has not previously begun issuing fines to pharmaceutical companies, this guidance brings that reality one step closer. Zach Weingarden, Product Solutions Manager, TrialAssure, helps clarify some common questions on this draft guidance that sponsors and other partners have been asking. Zach Weingarden, Product Solutions Manager, TrialAssure

Questions answered on FDA’s draft guidance on civil money penalties for ClinicalTrials.gov

by Staff Writer | October 2018

Posted in Blog
Read More
FDA issues draft guidance on civil monetary penalties for ClinicalTrials.gov clinical trial disclosure transparency trialassure company service solution technology software

This week in transparency news: September 15-28, 2018

by Staff Writer | September 2018

Posted in Blog
Read More
trialassure clinical trial transparency news

This week in transparency news: September 8-14, 2018

by Staff Writer | September 2018

Posted in Blog
Read More

This week in transparency news: August 25 – September 7, 2018

by Staff Writer | September 2018

Posted in Blog
Read More
trialassure clinical trial transparency news

This week in transparency: August 18 – August 24, 2018

by Staff Writer | August 2018

Posted in Blog
Read More

This week in transparency news: August 10 – August 17, 2018

by Staff Writer | August 2018

Posted in Blog
Read More
Get in Touch

Looking to streamline your clinical trial disclosure and transparency efforts?

TrialAssure is ready to help your organization embark on a Transparency Transformation!

To learn more about the TrialAssure Transparency Suite, specific products, or our company, contact us below.

Yes, please send me more information about TrialAssure.

  • *